TWD 35.25
(1.73%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | -117.51 Million | 439.76 Million | 349.75 Million | 246.87 Million | 102.91 Million |
Net Income | 91.53 Million | 318.2 Million | 245.29 Million | 27.07 Million | 96.54 Million |
Depreciation & Amortization | 55.13 Million | 65.34 Million | 67.46 Million | 73.81 Million | 79.87 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | 2.06 Million | 5.75 Million | 6.32 Million | 1.63 Million | - |
Change in working capital | -147.17 Million | 214.17 Million | 37.43 Million | 110.9 Million | -52.34 Million |
Other non-cash items | -27.01 Million | -8.73 Million | 2.72 Million | 3.01 Million | 336.66 Million |
Investing Cash Flow | -175.45 Million | -8.43 Million | -29.35 Million | -136.05 Million | -90.72 Million |
Investments in PPE | -80.03 Million | -140.26 Million | -43.87 Million | -168.46 Million | -7.71 Million |
Acquisitions | 123 Thousand | 3 Million | -10 Million | - | 1.58 Million |
Investment purchases | -151.16 Million | -15.54 Million | -65.59 Million | -16.86 Million | -84.58 Million |
Sales/Maturities of investments | 17.65 Million | 129.01 Million | -8.38 Million | 39.8 Million | - |
Other Investing Activities | 381 Thousand | 334 Thousand | 3.89 Million | 3.42 Million | - |
Financing Cash Flow | -153.46 Million | -132 Thousand | -237.46 Million | 39.41 Million | 17.97 Million |
Debt repayment | -68.47 Million | -90.08 Million | -210.57 Million | -105.64 Million | -135.28 Million |
Dividends payments | -96.07 Million | -93.85 Million | -23.46 Million | -58.65 Million | -117.31 Million |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 18.55 Million | 6.6 Million | - | - | - |
Other Financing Activities | -7.46 Million | 3.25 Million | 5 Million | - | - |
Accounts receivables | 185.08 Million | 535.66 Million | -339.23 Million | -157.92 Million | 106.4 Million |
Accounts payables | -238.98 Million | -163.23 Million | 182.84 Million | 83.52 Million | -30.42 Million |
Inventory | 220.02 Million | -621.23 Million | -99.76 Million | 38.41 Million | -274.06 Million |
Other working capital | -313.3 Million | 466.61 Million | 289.99 Million | 146.99 Million | 145.74 Million |
Cash at beginning of period | 1.44 Billion | 1.01 Billion | 941.98 Million | 797.15 Million | 779.68 Million |
Cash at end of period | 988.13 Million | 1.44 Billion | 1.01 Billion | 941.98 Million | 797.15 Million |
Capital Expenditure | -80.03 Million | -140.26 Million | -43.87 Million | -168.46 Million | -7.71 Million |
Effect of forex changes on cash | -7.82 Million | -8.63 Million | -5.08 Million | -5.4 Million | - |
Net cash flow / Change in cash | -454.26 Million | 422.56 Million | 77.85 Million | 144.82 Million | 17.47 Million |
Free Cash Flow | -197.55 Million | 299.49 Million | 305.88 Million | 78.4 Million | 95.19 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -8.87 Million | 26.51 Million | -26.39 Million | 91.53 Million | 35.4 Million | 63 Million |
Depreciation & Amortization | 12.74 Million | 12.37 Million | 12.26 Million | 55.13 Million | 13.92 Million | 14.45 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 257 Thousand | 256 Thousand | 259 Thousand | 2.07 Million | 603 Thousand | 604 Thousand |
Change in working capital | -45.42 Million | -56.16 Million | 103.25 Million | -147.17 Million | -63.12 Million | -43.39 Million |
Other non-cash items | -2.16 Million | -4.55 Million | -10.39 Million | -27.01 Million | -4.28 Million | -6.2 Million |
Investing Cash Flow | -25.78 Million | -163.78 Million | -86.87 Million | -175.45 Million | -69.08 Million | -27.43 Million |
Investments in PPE | -23.41 Million | -14.56 Million | -10.66 Million | -80.03 Million | -16.47 Million | -36.18 Million |
Acquisitions | - | - | -1000.00 | 123 Thousand | - | 124 Thousand |
Investment purchases | -4.05 Million | -156.64 Million | -87.83 Million | -151.16 Million | -21.63 Million | -2.09 Million |
Sales/Maturities of investments | - | 1.32 Million | 580 Thousand | 17.65 Million | -38.62 Million | 576 Thousand |
Other Investing Activities | 1.68 Million | -1.04 Million | 117 Thousand | 381 Thousand | 151 Thousand | 15 Thousand |
Financing Cash Flow | 77.41 Million | -5.49 Million | -64.29 Million | -153.46 Million | -76.54 Million | -10.24 Million |
Debt repayment | -79.16 Million | -6.1 Million | -69.34 Million | -68.47 Million | -17.86 Million | -8.5 Million |
Dividends payments | - | - | - | -96.07 Million | -96.07 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 2.53 Million | 6.75 Million | 18.55 Million | 3.56 Million | - |
Other Financing Activities | 85 Million | - | - | - | - | - |
Accounts receivables | -20.86 Million | -34.4 Million | 75.96 Million | 185.08 Million | -39.42 Million | 70.48 Million |
Accounts payables | 2.23 Million | 47 Thousand | -13.89 Million | -238.98 Million | -45.92 Million | -91.41 Million |
Inventory | 60.39 Million | 20.42 Million | 100.13 Million | 220.02 Million | 68.27 Million | 143.4 Million |
Other working capital | -87.18 Million | -42.23 Million | -58.94 Million | -313.3 Million | -46.04 Million | -165.86 Million |
Cash at beginning of period | 798.72 Million | 988.13 Million | 1.04 Billion | 1.44 Billion | 1.24 Billion | 1.33 Billion |
Cash at end of period | 823.41 Million | 798.72 Million | 988.13 Million | 988.13 Million | 1.04 Billion | 1.24 Billion |
Capital Expenditure | -23.41 Million | -14.56 Million | -10.66 Million | -80.03 Million | -16.47 Million | -36.18 Million |
Effect of forex changes on cash | 525 Thousand | -145 Thousand | -9.96 Million | -7.82 Million | -2.48 Million | 9.86 Million |
Net cash flow / Change in cash | 24.69 Million | -189.41 Million | -56.83 Million | -454.26 Million | -199.78 Million | -86.08 Million |
Free Cash Flow | -50.87 Million | -34.55 Million | 93.63 Million | -197.55 Million | -68.13 Million | -94.45 Million |
SCBGF
DLTI
MTH
5301
5941
CMPRF